Combining treatments boosts some smokers' ability to quit

June 17, 2014, Duke University Medical Center

Combining two smoking cessation therapies is more effective than using just one for male and highly nicotine-dependent smokers who weren't initially helped by the nicotine patch, according to researchers at Duke Medicine.

The findings, published online June 17, 2014, in the American Journal of Psychiatry, also support using an adaptive treatment model to determine which are likely to succeed in quitting with nicotine replacement alone before trying additional therapies.

"The findings offer a potential practical treatment approach that can identify smokers who don't respond to a single conventional treatment, but may benefit enormously from a combination of treatments," said Jed Rose, Ph.D., director of the Duke Center for Smoking Cessation and the study's lead author.

Rose and his colleagues have developed adaptive models for that tailor treatment regimens based on a person's likelihood of successfully quitting. Smokers start using a nicotine patch prior to quitting, and based on their reduction in smoking, researchers then determine who is likely to successfully quit with or without additional treatments.

"Using a safe and inexpensive nicotine patch, we can predict a smoker's success or failure," Rose said. "If a smoker has a low likelihood of succeeding, we can avert failure before it happens using a step-by-step algorithm to switch a smoker to a treatment that's more likely to help."

Current smoking cessation treatments – including , bupropion (sold under the brand name Zyban) and varenicline (sold as Chantix) – have modest long-term success rates. Research has shown that less than 25 percent of smokers remain abstinent a year after treatment.

"It's clear that we need to improve success rates for smoking cessation, and it is thought that combining treatments could add to the efficacy," Rose said. "Combining two therapies, especially if they act by different mechanisms, may address different aspects of the addiction."

To measure the benefit of combining treatments, the researchers enrolled 349 adults who reported smoking 10 or more cigarettes a day. A six-item questionnaire measured the smokers' level of nicotine dependence. All participants were given prior to quitting.

After a week on the nicotine patch, the 222 participants who did not cut their smoking by 50 percent while on the patch were randomly assigned to take either varenicline and a placebo or a combination of varenicline and bupropion.

The participants took the assigned treatments for 12 weeks, and were followed periodically for six months. The varenicline and bupropion were generally well tolerated, with side effects including headache, dry mouth, irritability, insomnia, vivid dreams and changes in taste.

The researchers observed an overall benefit of adding bupropion to varenicline, with 39.8 percent of participants on the combination treatment abstaining from smoking at weeks 8-11 after the target quit date, versus 25.9 percent taking varenicline alone.

The combined treatment had a much greater effect on male smokers and those highly dependent on nicotine, while no significant difference was seen in female smokers or those with lower levels of .

Smokers who were both male and highly dependent saw the greatest benefit of the combination of treatments.

"Highly dependent male smokers had a boost in quit rates from 14 percent on alone to 61 percent with the combination treatment, which is a dramatic increase," Rose said.

"While there may be some drawbacks to prescribing two smoking cessation treatments, such as cost or possible side effects, this study gives us a simple strategy to find those who would benefit the most from combined treatment, and spare others who may not benefit."

The researchers said additional studies are needed to investigate the mechanisms that may account for the differences in treatment responses across genders and other populations of smokers.

Explore further: Combination therapy does not improve ability to quit smoking after one year

Related Stories

Combination therapy does not improve ability to quit smoking after one year

January 7, 2014
Among cigarette smokers, the combined use of the smoking cessation medications varenicline and bupropion, compared with varenicline alone, resulted in better rates of smoking abstinence at 12 weeks, but rates were similar ...

Study finds that smokers who try e-cigarettes to quit are younger and more motivated to quit

July 23, 2013
University of Hawaii Cancer Center Prevention and Control Program researchers Pallav Pokhrel, PhD and Thaddeus Herzog, PhD have found that smokers who use e-cigarettes as a tool to stop smoking tend to be younger and more ...

Smoking cessation trial prompts call for subsidies on wider range of quit therapies

May 29, 2014
Community smoking-cessation workers are calling for the government to subsidise a wider range of nicotine replacement therapies so that smokers can afford to use products that are proving to be more popular and effective ...

Quitting smoking: Licensed medications are effective

May 30, 2013
Nicotine replacement therapy and other licensed drugs can help people quit smoking, according to a new systematic review published in The Cochrane Library. The study, which is an overview of previous Cochrane reviews, supports ...

Nicotine patches do not appear to help pregnant smokers to quit

March 11, 2014
Smoking during pregnancy increases the risk of adverse pregnancy and birth outcomes and may have long lasting effects in offspring.

Stronger nicotine dependence correlates with higher post-smoking weight gain

August 21, 2013
Smokers with more severe nicotine dependence are more likely to gain weight when they try to quit, according to research published August 21 in the open access journal PLOS ONE by Koji Hasegawa and colleagues from Kyoto Medical ...

Recommended for you

Intensive behavior therapy no better than conventional support in treating teenagers with antisocial behavior

January 19, 2018
Research led by UCL has found that intensive and costly multisystemic therapy is no better than conventional therapy in treating teenagers with moderate to severe antisocial behaviour.

Babies' babbling betters brains, language

January 18, 2018
Babies are adept at getting what they need - including an education. New research shows that babies organize mothers' verbal responses, which promotes more effective language instruction, and infant babbling is the key.

College branding makes beer more salient to underage students

January 18, 2018
In recent years, major beer companies have tried to capitalize on the salience of students' university affiliations, unveiling marketing campaigns and products—such as "fan cans," store displays, and billboard ads—that ...

Inherited IQ can increase in early childhood

January 18, 2018
When it comes to intelligence, environment and education matter – more than we think.

Baby brains help infants figure it out before they try it out

January 17, 2018
Babies often amaze their parents when they seemingly learn new skills overnight—how to walk, for example. But their brains were probably prepping for those tasks long before their first steps occurred, according to researchers.

Reducing sessions of trauma-focused psychotherapy does not affect effectiveness

January 17, 2018
Posttraumatic Stress Disorder (PTSD) patients treated with as few as five sessions of trauma-focused psychotherapy find it equally effective as receiving 12 sessions.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.